Indian firms said that the Bangladeshi company with which Mantralaya
is in talks has neither the import licence, nor a manufacturing
licence from Gilead to sell the drug in India.
https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/maharashtras-plan-to-buy-drug-from-bangladesh-irks-local-companies/articleshow/76251008.cms
No comments:
Post a Comment